Clinical Trials Browser

Completed × Lymphoma, Non-Hodgkin × epratuzumab × Clear all

NCT00421395 2021-08-16

Safety Study of NHL With 90Y-hLL2 IgG

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT00398372 2011-06-02

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment

Phase NA Completed

Lymphoma, Non-Hodgkin

NCT00044902 2007-12-28

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Phase 2 Completed

Lymphoma, Non-Hodgkin